ceftizoxime-alapivoxil and Gram-Negative-Bacterial-Infections

ceftizoxime-alapivoxil has been researched along with Gram-Negative-Bacterial-Infections* in 1 studies

Other Studies

1 other study(ies) available for ceftizoxime-alapivoxil and Gram-Negative-Bacterial-Infections

ArticleYear
AS-924, a novel bifunctional prodrug of ceftizoxime.
    The Journal of antibiotics, 1999, Volume: 52, Issue:5

    To improve the oral absorption of ceftizoxime (CZX), 7beta-[(Z)-2-(2-aminothiazol-4-yl)-2-methoxyiminoacetamido]- 3-cephem-4- carboxylic acid, we synthesized and evaluated a novel series of bifunctional prodrugs, in which L-alanine was introduced into the aminothiazole-oxime moiety at the C-7 position of the various lipophilic esters of CZX. Among these prodrugs, pivaloyloxymethyl 7beta-[(Z)-2-(2-(S)-alanylaminothiazol-4-yl)-2-methoxyiminoa cetamido]-3-cephem-4-carboxylate hydrochloride (ceftizoxime alapivoxil, AS-924) was well absorbed after oral administration in experimental animals and showed potent therapeutic effects in mice infected with gram-positive and gram-negative bacteria.

    Topics: Animals; Bacteria; Ceftizoxime; Cephalosporins; Dogs; Gram-Negative Bacterial Infections; Gram-Positive Bacterial Infections; Male; Mice; Microbial Sensitivity Tests; Molecular Structure; Prodrugs; Rabbits; Rats; Rats, Wistar

1999